MARY MIDDAGH: Open Payments
NPI 1396279709 · HELENA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,051 in 56 payments from 11 companies in 2025. Trend: 2023 $555 · 2024 $479 · 2025 $4,051
Speaker / faculty: $2,096Food & beverage: $1,005Consulting: $950
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $2,264 |
| Regeneron Healthcare Solutions, Inc. | 13 | $1,087 |
| ABBVIE INC. | 18 | $376 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $182 |
| Ipsen Biopharmaceuticals, Inc | 2 | $31 |
| Novo Nordisk Inc | 1 | $24 |
| TerSera Therapeutics LLC | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Ardelyx, Inc. | 1 | $15 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, ENTYVIO, MAVYRET, EOHILIA, IQIRVO, Wegovy.
Industry payments across MT — which companies pay providers there.
